Population pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in aspirin-treated patients with stable coronary artery disease C. Steven Ernest IIDavid S. SmallRebecca E. Wrishko OriginalPaper 21 November 2008 Pages: 593 - 618
An interface model for dosage adjustment connects hematotoxicity to pharmacokinetics C. MeilleA. IliadisG. Freyer OriginalPaper 24 December 2008 Pages: 619 - 633
Drug–drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 1: comparison of uniresponse and multiresponse designs using PopDes Marylore ChenelFrançois BouzomKayode Ogungbenro OriginalPaper 07 January 2009 Pages: 635 - 659
Drug–drug interaction predictions with PBPK models and optimal multiresponse sampling time designs: application to midazolam and a phase I compound. Part 2: clinical trial results Marylore ChenelFrançois BouzomFrance Mentré OriginalPaper 07 January 2009 Pages: 661 - 681
Comparing models for perfluorooctanoic acid pharmacokinetics using Bayesian analysis John F. WambaughHugh A. BartonR. Woodrow Setzer OriginalPaper 08 January 2009 Pages: 683 - 712